GlassScriptPhysician profile
Nicholas Rizzo
NPI 1669447272
$645.07
in general payments reported to CMS, 2019-2025
11 companies · $37.94 in 2025
The $37.94 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $47.93 · 2021: $42.20 · 2022: $70.51 · 2023: $221 · 2024: $65.86 · 2025: $37.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $302.22 | 2021-2025 | |
| Esperion Therapeutics, INC. | $120.20 | 2023 | Nexlizet, Nexletol |
| Novo Nordisk INC | $55.41 | 2019 | |
| Novartis Pharmaceuticals Corporation | $31.01 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $30.68 | 2019-2020 | |
| Abbott Laboratories | $28.46 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.25 | 2020 | |
| Hikma Pharmaceuticals USA | $15.72 | 2019 | |
| Exact Sciences Corporation | $15.35 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $14.42 | 2019 | |
| Redhill Biopharma INC. | $13.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Rizzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.